G9060 HCPCS Level II Code: Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a…
Medicare Coverage & Payment
- CMS short descriptor: Onc prac mgmt dif pt comorb
- Medicare coverage: Not payable by Medicare (CMS coverage code I)
- Payment category: Service not separately priced (pricing indicator 00)
- BETOS: P7B — Oncology - other
- Last CMS action effective: January 1, 2007
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Contextual Map
Every relationship of G9060 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- G9017 — Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9018 — Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9019 — Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9020 — Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9033 — Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9034 — Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9035 — Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)[Sibling]
- G9036 — Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)[Sibling]
- and 32 more
Change history
- January 1, 2006 — Added to the code set [Change history]
Sources for this page
Every coding fact on this page is read from the datasets below. Nothing is AI-generated; MedCoder-derived relationships and editorial are labelled where they appear.
- Code, descriptors, coverage and pricing attributes
- CMS HCPCS Alpha-Numeric (ANWEB) release — July 2026 quarterly update
- Change history and date-of-service validity
- CMS HCPCS quarterly update files, ingested into the change ledger
- Comparisons, relationships and the contextual map MedCoder-derived
- Derived by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
Change history
- January 1, 2006Added to the code setOncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)
Nearest Codes in This Family
Official HCPCS Level II classifications closest to G9060 in its code family, with their registry titles.
- G9055 — Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)
- G9056 — Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)
- G9057 — Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved…
- G9058 — Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)
- G9059 — Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management,…
- G9061 — Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project)
- G9062 — Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)
- G9063 — Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression,…
- G9064 — Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression,…
- G9065 — Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease…